Livermore DM, Mushtaq S, Warner M, Zhang J-C, Maharjan S, Doumith M, Woodford N
Prevents Type 2 Diabetes Progression By improving insulin sensitivity and beta-cell function Supports Cardiovascular Health Reduces blood pressure, LDL cholesterol, and inflammation Lowers Risk of Fatty Liver Disease (NAFLD/NASH) Helps reduce liver fat accumulation Improves PCOS Symptoms Regulates ovulation, insulin resistance, and weight in women with PCOS May Benefit Neuroprotection Early studies suggest a role in reducing neuroinflammation and cognitive decline Contraindications These GLP-1s are generally well-tolerated, but some patients should not take them
these are common class effects of GLP-1 receptor agonists Gallbladder disease: cholelithiasis (gallstones) and cholecystitis have been reported as class-associated risks with GLP-1 receptor agonists
: The FDA removed 12 peptides including BPC-157, TB-500, KPV, and MOTS-C from Category 2 (substances prohibited from compounding) due to original nominators withdrawing their submissions
However, it is important to understand that the effectiveness of this treatment can vary from person to person, as several factors can influence the overall success of the weight loss journey
However, this increase in myofibroblastic marker expression was not reflected at the protein level for either SMA (Fig